Block listing Interim Review
Updated : 12:45
24 May 2019
Cello Health plc
("Cello" or the "Company")
Additional Block Listing of Ordinary Shares
Block Listing Update
The Company announces that an application has been made to the London Stock Exchange for a block admission for 2,368,200 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.
These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. The new Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company. Admission of the new Ordinary Shares is expected to occur on 31 May 2019.
Further to the announcement by the Company on 14 December 2018, the Company also announces that a total of 61,061 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted since that date (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.
Enquires
Cello Health | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director | |
Cenkos Securities | 020 7397 8900 |
Mark Connelly | |
Harry Hargreaves | |
Buchanan | 020 7466 5000 |
Mark Court | |
Jamie Hooper | |
Sophie Wills |
BLOCK LISTING SIX MONTHLY RETURN
Name of applicant: | Cello Health plc | |||
Name of scheme: | PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010 | |||
Period of return: | From: | 31 November 2018 | To: | 23 May 2019 |
Balance of unallotted securities under scheme(s) from previous return: | 611,608 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 2,368,200 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | (61,061) | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,918,747 | |||
Name of contact: | Mark Bentley, Group Finance Director | |||
Telephone number of contact: | 020 7812 8460 | |||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.